SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 103 filers reported holding SAGENT PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $251,000 | +37.9% | 16,761 | +11.8% | 0.00% | 0.0% |
| Q1 2016 | $182,000 | -26.9% | 14,990 | -4.4% | 0.00% | 0.0% |
| Q4 2015 | $249,000 | +6.9% | 15,676 | +3.0% | 0.00% | 0.0% |
| Q3 2015 | $233,000 | -33.4% | 15,220 | +5.8% | 0.00% | 0.0% |
| Q2 2015 | $350,000 | -6.4% | 14,381 | -10.7% | 0.00% | -50.0% |
| Q1 2015 | $374,000 | -11.2% | 16,096 | -3.9% | 0.00% | 0.0% |
| Q4 2014 | $421,000 | -19.5% | 16,750 | -0.3% | 0.00% | 0.0% |
| Q3 2014 | $523,000 | +21.3% | 16,808 | +0.9% | 0.00% | 0.0% |
| Q2 2014 | $431,000 | +26.0% | 16,660 | +13.9% | 0.00% | 0.0% |
| Q1 2014 | $342,000 | -7.3% | 14,632 | +0.6% | 0.00% | 0.0% |
| Q4 2013 | $369,000 | +30.9% | 14,545 | +5.3% | 0.00% | +100.0% |
| Q3 2013 | $282,000 | +41.0% | 13,807 | +44.9% | 0.00% | 0.0% |
| Q2 2013 | $200,000 | – | 9,528 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|